Relaxin: Difference between revisions
Gerald Chi (talk | contribs) |
→Structure: Added content |
||
Line 1: | Line 1: | ||
{{protein | {{for|the [[Miles Davis]] album|Relaxin' with the Miles Davis Quintet}} | ||
{{infobox protein | |||
| Name = Relaxin 1 | | Name = Relaxin 1 | ||
| caption = | | caption = | ||
| image = | | image = relaxin.png | ||
| width = | | width = | ||
| HGNCid = 10026 | | HGNCid = 10026 | ||
| Symbol = RLN1 | | Symbol = RLN1 | ||
| AltSymbols = | | AltSymbols = H1 | ||
| EntrezGene = 6013 | | EntrezGene = 6013 | ||
| OMIM = 179730 | | OMIM = 179730 | ||
| RefSeq = | | RefSeq = NM_006911 | ||
| UniProt = | | UniProt = P04808 | ||
| PDB = | | PDB = | ||
| ECnumber = | | ECnumber = | ||
Line 18: | Line 19: | ||
| LocusSupplementaryData = -q12 | | LocusSupplementaryData = -q12 | ||
}} | }} | ||
{{protein | {{infobox protein | ||
| Name = Relaxin 2 | | Name = Relaxin 2 | ||
| caption = | | caption = | ||
Line 25: | Line 26: | ||
| HGNCid = 10027 | | HGNCid = 10027 | ||
| Symbol = RLN2 | | Symbol = RLN2 | ||
| AltSymbols = | | AltSymbols = H2, RLXH2, bA12D24.1.1, bA12D24.1.2 | ||
| EntrezGene = 6019 | | EntrezGene = 6019 | ||
| OMIM = 179740 | | OMIM = 179740 | ||
| RefSeq = | | RefSeq = NM_134441 | ||
| UniProt = | | UniProt = P04090 | ||
| PDB = | | PDB = 6RLX | ||
| ECnumber = | | ECnumber = | ||
| Chromosome = 9 | | Chromosome = 9 | ||
Line 37: | Line 38: | ||
| LocusSupplementaryData = -q12 | | LocusSupplementaryData = -q12 | ||
}} | }} | ||
{{protein | {{infobox protein | ||
| Name = Relaxin 3 | | Name = Relaxin 3 | ||
| caption = | | caption = | ||
Line 44: | Line 45: | ||
| HGNCid = 17135 | | HGNCid = 17135 | ||
| Symbol = RLN3 | | Symbol = RLN3 | ||
| AltSymbols = | | AltSymbols = ZINS4, RXN3, H3 | ||
| EntrezGene = 117579 | | EntrezGene = 117579 | ||
| OMIM = 606855 | | OMIM = 606855 | ||
| RefSeq = | | RefSeq = NM_080864 | ||
| UniProt = | | UniProt = Q8WXF3 | ||
| PDB = | | PDB = | ||
| ECnumber = | | ECnumber = | ||
Line 56: | Line 57: | ||
| LocusSupplementaryData = | | LocusSupplementaryData = | ||
}} | }} | ||
'''Relaxin''' is a [[protein]] [[hormone]] of about 6000 Da<ref name="pmid9112071">{{cite journal | author = Bani D | title = Relaxin: a pleiotropic hormone. | journal = General pharmacology | volume = 28 | issue = 1 | pages = 13–22 | date = January 1997 | pmid = 9112071 | doi=10.1016/s0306-3623(96)00171-1}}</ref> first described in 1926 by Frederick Hisaw.<ref name="urlIf a Gopher Can Do It ... - TIME">{{cite web | url = http://www.time.com/time/magazine/article/0,9171,796530,00.html | title = If a Gopher Can Do It ... | date = 1944-04-10 | work = | publisher = Time Magazine | pages = | language = | archiveurl = | archivedate = | quote = | accessdate = 2009-05-20}}</ref><ref name="pmid11231378">{{cite journal |vauthors=Becker GJ, Hewitson TD | title = Relaxin and renal fibrosis | journal = Kidney Int. | volume = 59 | issue = 3 | pages = 1184–5 | date = March 2001 | pmid = 11231378 | doi = 10.1046/j.1523-1755.2001.0590031184.x | url = }}</ref> | |||
'''Relaxin''' is a [[ | |||
The relaxin-like peptide family belongs in the insulin superfamily and consists of 7 peptides of high structural but low sequence similarity; relaxin-1 ([[RLN1]]), 2 ([[RLN2]]) and 3 ([[RLN3]]), and the insulin-like (INSL) peptides, [[INSL3]], [[INSL4]], [[INSL5]] and [[INSL6]]. The functions of relaxin-3, INSL4, INSL5, INSL6 remain uncharacterised.<ref name="pmid15707501">{{cite journal |vauthors=Wilkinson TN, Speed TP, Tregear GW, Bathgate RA | title = Evolution of the relaxin-like peptide family | journal = BMC Evolutionary Biology | volume = 5 | pages = 14 | date = February 2005 | pmid = 15707501 | pmc = 551602 | doi = 10.1186/1471-2148-5-14 | url = }}</ref> | |||
== | ==Synthesis== | ||
In the female, it is produced by the [[corpus luteum]] of the [[ovary]], the [[breast]] and, during [[pregnancy]], also by the [[placenta]], [[chorion]], and [[decidua]]. | In the female, it is produced by the [[corpus luteum]] of the [[ovary]], the [[breast]] and, during [[pregnancy]], also by the [[placenta]], [[chorion]], and [[decidua]]. | ||
In the male, | In the male, it is produced in the prostate and is present in human semen.<ref name="pmid2011710">{{cite journal | author = MacLennan AH | title = The role of the hormone relaxin in human reproduction and pelvic girdle relaxation | journal = Scandinavian journal of rheumatology. Supplement | volume = 88 | issue = | pages = 7–15 | year = 1991 | pmid = 2011710 | doi = | url = }}</ref> | ||
==Structure== | ==Structure== | ||
Structurally, relaxin is a [[heterodimer]] of two peptide chains of 24 and 29 [[amino acid]]s | {{See also|Insulin/IGF/Relaxin family}} | ||
Relaxin is produced from its [[prohormone]], | Structurally, relaxin is a [[heterodimer]] of two peptide chains of 24 and 29 [[amino acid]]s linked by [[disulfide]] bridges, and it appears related to [[insulin]]. | ||
Relaxin is produced from its [[prohormone]], "prorelaxin", by splitting off one additional peptide chain reaction. | |||
==Function== | ==Function== | ||
In animals relaxin widens the [[pubic bone]] and facilitates [[childbirth|labor]] | ===In humans=== | ||
In females, relaxin is produced mainly by the corpus luteum, in both pregnant <ref name="pmid9112071" /> and nonpregnant<ref name="pmid9112071" /> females; it rises to a peak within approximately 14 days of [[ovulation]], and then declines in the absence of pregnancy, resulting in [[menstruation]] {{Citation needed|date=August 2013}}). During the first trimester of pregnancy, levels rise and additional relaxin is produced by the decidua. Relaxin's peak is reached during the 14 weeks of the first trimester and at delivery. It is known to mediate the hemodynamic changes that occur during pregnancy, such as increased cardiac output, increased renal blood flow, and increased arterial compliance. It also relaxes other pelvic ligaments.<ref name="pmid21613576">{{cite journal | author = Conrad KP | title = Maternal vasodilation in pregnancy: the emerging role of relaxin | journal = Am. J. Physiol. Regul. Integr. Comp. Physiol. | volume = 301 | issue = 2 | pages = R267–75 | date = August 2011 | pmid = 21613576 | pmc = 3154715 | doi = 10.1152/ajpregu.00156.2011 }}</ref> It is believed to soften the [[pubic symphysis]]. | |||
In males, relaxin enhances motility of sperm in semen.<ref name="pmid2497805">{{cite journal | author = Weiss G | title = Relaxin in the male | journal = Biol. Reprod. | volume = 40 | issue = 2 | pages = 197–200 | date = February 1989 | pmid = 2497805 | doi = 10.1095/biolreprod40.2.197 | url = http://www.biolreprod.org/cgi/reprint/40/2/197 }}</ref> | |||
===In other animals=== | |||
In animals, relaxin widens the [[pubic bone]] and facilitates [[childbirth|labor]]; it also softens the [[cervix]] (cervical ripening), and relaxes the uterine musculature. Thus, for a long time, relaxin was looked at as a pregnancy hormone. However, its significance may reach much further. Relaxin affects [[collagen]] metabolism, inhibiting collagen synthesis and enhancing its breakdown by increasing [[matrix metalloproteinase]]s.<ref>{{cite journal |vauthors=Mookerjee I, Solly NR, Royce SG, Tregear GW, Samuel CS, Tang ML | title = Endogenous relaxin regulates collagen deposition in an animal model of allergic airway disease | journal = Endocrinology | volume = 147 | issue = 2 | pages = 754–61 | year = 2006 | pmid = 16254028 | doi = 10.1210/en.2005-1006 }}</ref> It also enhances [[angiogenesis]] and is a potent renal [[vasodilator]]. | |||
In the European Rabbit, (''Oryctolagus cuniculus''), relaxin<ref name="Arroyo_2012">{{cite journal | vauthors = Arroyo JI, Hoffmann FG, Opazo JC | title = Gene duplication and positive selection explains unusual physiological roles of the relaxin gene in the European rabbit | journal = Journal of Molecular Evolution | volume = 74 | issue = 1-2 | pages = 52–60 | year = 2012 | pmid = 22354201 | doi = 10.1007/s00239-012-9487-2 }}</ref> is associated with squamous differentiation and is expressed in tracheobronchial epithelial cells as opposed to being involved with reproduction. | |||
==Receptors== | ==Receptors== | ||
Relaxin interacts with the [[relaxin receptor]] LGR7 ( | Relaxin interacts with the [[relaxin receptor]] LGR7 ([[RXFP1]]) and LGR8 ([[RXFP2]]), which belong to the [[G protein-coupled receptor]] superfamily.<ref>{{cite journal |vauthors=Hsu SY, Nakabayashi K, Nishi S, Kumagai J, Kudo M, Sherwood OD, Hsueh AJ | title = Activation of orphan receptors by the hormone relaxin | journal = Science | volume = 295 | issue = 5555 | pages = 674–6 | year = 2002 | pmid = 11809971 | doi = 10.1126/science.1065654 }}</ref> They contain a heptahelical [[Transmembrane helix|transmembrane domain]] and a large glycosylated ectodomain, distantly related to the receptors for the glycoproteohormones, such as the [[LH-receptor]] or [[FSH-receptor]]. | ||
Relaxin receptors have been found in the [[heart]], [[smooth muscle]], the [[connective tissue]], and central and [[autonomous nervous system]]. | Relaxin receptors have been found in the [[heart]], [[smooth muscle]], the [[connective tissue]], and central and [[autonomous nervous system]]. | ||
==Disorders== | ==Disorders== | ||
Specific disorders related to relaxin have not been described, yet | Specific disorders related to relaxin have not been described, yet a link to [[scleroderma]] and [[fibromyalgia]] has been suggested.<ref>{{cite journal |vauthors=Van Der Westhuizen ET, Summers RJ, Halls ML, Bathgate RA, Sexton PM | title = Relaxin receptors--new drug targets for multiple disease states | journal = Curr Drug Targets | volume = 8 | issue = 1 | pages = 91–104 | year = 2007 | pmid = 17266534 | doi = 10.2174/138945007779315650 }}</ref> | ||
== | ==Pharmacological targets== | ||
< | |||
< | A recombinant form of human relaxin-2 has been developed as investigational drug RLX030 ([[serelaxin]]). | ||
== Evolution == | |||
Relaxin 1 and Relaxin 2 arose from the duplication of a proto-RLN gene between 44.2 and 29.6 million years ago in the last common ancestor of catarrhine primates.<ref name="Arroyo_2014">{{cite journal | vauthors = Arroyo JI, Hoffmann FG, Opazo JC | title = Evolution of the relaxin/insulin-like gene family in anthropoid primates | journal = Genome Biology and Evolution | volume = 6 | issue = 3 | pages = 491–9 | year = 2014 | pmid = 24493383 | doi = 10.1093/gbe/evu023 | url = }}</ref> The duplication that led to RLN1 and RLN2 is thought to have been a result of positive selection and convergent evolution at the nucleotide level between the relaxin gene in New World monkeys and the RLN1 gene in apes .<ref name="Arroyo_2014" /> As a result, Old World monkeys, a group that includes the subfamilies colobines and cercopithecines, have lost the RLN1 paralog, but apes have retained both the RLN1 and the RLN2 genes <ref name="Arroyo_2014" />; Lawrence and Cords, 2012). | |||
==See also== | |||
* [[Relaxin family peptide hormones]] | |||
* [[Insulin/IGF/Relaxin' family]] | |||
* [[Relaxin'/insulin-like family peptide receptor 1]] | |||
== References == | |||
{{Reflist|2}} | |||
==External links== | ==External links== | ||
* | * {{MeshName|Relaxin'}} | ||
* {{cite web | url = http://www.hprd.org/resultsQuery?multiplefound=&prot_name=Relaxin&external=Ref_seq&accession_id=&hprd=&gene_symbol=&chromo_locus=&function=&ptm_type=&localization=&domain=&motif=&expression=&prot_start=&prot_end=&limit=0&mole_start=&mole_end=&disease=&query_submit=Search | title = Relaxin | work = Human Protein Reference Database | publisher = Johns Hopkins University and the Institute of Bioinformatics | accessdate = 2009-05-20}} | |||
{{Hormones}} | |||
{{ | {{Protein and peptide receptor modulators}} | ||
{{Authority control}} | |||
[[Category:Peptide hormones]] | [[Category:Peptide hormones]] | ||
[[Category: | [[Category:Hormones of the ovary]] | ||
[[Category:Hormones of the placenta]] | |||
[[Category:Hormones of the pregnant female]] | |||
[[Category:Human female endocrine system]] | |||
[[ | |||
[[ | |||
[[ |
Revision as of 06:45, 29 November 2017
Relaxin 1 | |
---|---|
File:Relaxin.png | |
Identifiers | |
Symbol | RLN1 |
Alt. symbols | H1 |
Entrez | 6013 |
HUGO | 10026 |
OMIM | 179730 |
RefSeq | NM_006911 |
UniProt | P04808 |
Other data | |
Locus | Chr. 9 qter-q12 |
Relaxin 2 | |
---|---|
Identifiers | |
Symbol | RLN2 |
Alt. symbols | H2, RLXH2, bA12D24.1.1, bA12D24.1.2 |
Entrez | 6019 |
HUGO | 10027 |
OMIM | 179740 |
PDB | 6RLX |
RefSeq | NM_134441 |
UniProt | P04090 |
Other data | |
Locus | Chr. 9 qter-q12 |
Relaxin 3 | |
---|---|
Identifiers | |
Symbol | RLN3 |
Alt. symbols | ZINS4, RXN3, H3 |
Entrez | 117579 |
HUGO | 17135 |
OMIM | 606855 |
RefSeq | NM_080864 |
UniProt | Q8WXF3 |
Other data | |
Locus | Chr. 19 p13.3 |
Relaxin is a protein hormone of about 6000 Da[1] first described in 1926 by Frederick Hisaw.[2][3]
The relaxin-like peptide family belongs in the insulin superfamily and consists of 7 peptides of high structural but low sequence similarity; relaxin-1 (RLN1), 2 (RLN2) and 3 (RLN3), and the insulin-like (INSL) peptides, INSL3, INSL4, INSL5 and INSL6. The functions of relaxin-3, INSL4, INSL5, INSL6 remain uncharacterised.[4]
Synthesis
In the female, it is produced by the corpus luteum of the ovary, the breast and, during pregnancy, also by the placenta, chorion, and decidua.
In the male, it is produced in the prostate and is present in human semen.[5]
Structure
Structurally, relaxin is a heterodimer of two peptide chains of 24 and 29 amino acids linked by disulfide bridges, and it appears related to insulin.
Relaxin is produced from its prohormone, "prorelaxin", by splitting off one additional peptide chain reaction.
Function
In humans
In females, relaxin is produced mainly by the corpus luteum, in both pregnant [1] and nonpregnant[1] females; it rises to a peak within approximately 14 days of ovulation, and then declines in the absence of pregnancy, resulting in menstruation [citation needed]). During the first trimester of pregnancy, levels rise and additional relaxin is produced by the decidua. Relaxin's peak is reached during the 14 weeks of the first trimester and at delivery. It is known to mediate the hemodynamic changes that occur during pregnancy, such as increased cardiac output, increased renal blood flow, and increased arterial compliance. It also relaxes other pelvic ligaments.[6] It is believed to soften the pubic symphysis.
In males, relaxin enhances motility of sperm in semen.[7]
In other animals
In animals, relaxin widens the pubic bone and facilitates labor; it also softens the cervix (cervical ripening), and relaxes the uterine musculature. Thus, for a long time, relaxin was looked at as a pregnancy hormone. However, its significance may reach much further. Relaxin affects collagen metabolism, inhibiting collagen synthesis and enhancing its breakdown by increasing matrix metalloproteinases.[8] It also enhances angiogenesis and is a potent renal vasodilator.
In the European Rabbit, (Oryctolagus cuniculus), relaxin[9] is associated with squamous differentiation and is expressed in tracheobronchial epithelial cells as opposed to being involved with reproduction.
Receptors
Relaxin interacts with the relaxin receptor LGR7 (RXFP1) and LGR8 (RXFP2), which belong to the G protein-coupled receptor superfamily.[10] They contain a heptahelical transmembrane domain and a large glycosylated ectodomain, distantly related to the receptors for the glycoproteohormones, such as the LH-receptor or FSH-receptor.
Relaxin receptors have been found in the heart, smooth muscle, the connective tissue, and central and autonomous nervous system.
Disorders
Specific disorders related to relaxin have not been described, yet a link to scleroderma and fibromyalgia has been suggested.[11]
Pharmacological targets
A recombinant form of human relaxin-2 has been developed as investigational drug RLX030 (serelaxin).
Evolution
Relaxin 1 and Relaxin 2 arose from the duplication of a proto-RLN gene between 44.2 and 29.6 million years ago in the last common ancestor of catarrhine primates.[12] The duplication that led to RLN1 and RLN2 is thought to have been a result of positive selection and convergent evolution at the nucleotide level between the relaxin gene in New World monkeys and the RLN1 gene in apes .[12] As a result, Old World monkeys, a group that includes the subfamilies colobines and cercopithecines, have lost the RLN1 paralog, but apes have retained both the RLN1 and the RLN2 genes [12]; Lawrence and Cords, 2012).
See also
- Relaxin family peptide hormones
- Insulin/IGF/Relaxin' family
- Relaxin'/insulin-like family peptide receptor 1
References
- ↑ 1.0 1.1 1.2 Bani D (January 1997). "Relaxin: a pleiotropic hormone". General pharmacology. 28 (1): 13–22. doi:10.1016/s0306-3623(96)00171-1. PMID 9112071.
- ↑ "If a Gopher Can Do It ..." Time Magazine. 1944-04-10. Retrieved 2009-05-20.
- ↑ Becker GJ, Hewitson TD (March 2001). "Relaxin and renal fibrosis". Kidney Int. 59 (3): 1184–5. doi:10.1046/j.1523-1755.2001.0590031184.x. PMID 11231378.
- ↑ Wilkinson TN, Speed TP, Tregear GW, Bathgate RA (February 2005). "Evolution of the relaxin-like peptide family". BMC Evolutionary Biology. 5: 14. doi:10.1186/1471-2148-5-14. PMC 551602. PMID 15707501.
- ↑ MacLennan AH (1991). "The role of the hormone relaxin in human reproduction and pelvic girdle relaxation". Scandinavian journal of rheumatology. Supplement. 88: 7–15. PMID 2011710.
- ↑ Conrad KP (August 2011). "Maternal vasodilation in pregnancy: the emerging role of relaxin". Am. J. Physiol. Regul. Integr. Comp. Physiol. 301 (2): R267–75. doi:10.1152/ajpregu.00156.2011. PMC 3154715. PMID 21613576.
- ↑ Weiss G (February 1989). "Relaxin in the male". Biol. Reprod. 40 (2): 197–200. doi:10.1095/biolreprod40.2.197. PMID 2497805.
- ↑ Mookerjee I, Solly NR, Royce SG, Tregear GW, Samuel CS, Tang ML (2006). "Endogenous relaxin regulates collagen deposition in an animal model of allergic airway disease". Endocrinology. 147 (2): 754–61. doi:10.1210/en.2005-1006. PMID 16254028.
- ↑ Arroyo JI, Hoffmann FG, Opazo JC (2012). "Gene duplication and positive selection explains unusual physiological roles of the relaxin gene in the European rabbit". Journal of Molecular Evolution. 74 (1–2): 52–60. doi:10.1007/s00239-012-9487-2. PMID 22354201.
- ↑ Hsu SY, Nakabayashi K, Nishi S, Kumagai J, Kudo M, Sherwood OD, Hsueh AJ (2002). "Activation of orphan receptors by the hormone relaxin". Science. 295 (5555): 674–6. doi:10.1126/science.1065654. PMID 11809971.
- ↑ Van Der Westhuizen ET, Summers RJ, Halls ML, Bathgate RA, Sexton PM (2007). "Relaxin receptors--new drug targets for multiple disease states". Curr Drug Targets. 8 (1): 91–104. doi:10.2174/138945007779315650. PMID 17266534.
- ↑ 12.0 12.1 12.2 Arroyo JI, Hoffmann FG, Opazo JC (2014). "Evolution of the relaxin/insulin-like gene family in anthropoid primates". Genome Biology and Evolution. 6 (3): 491–9. doi:10.1093/gbe/evu023. PMID 24493383.
External links
- Relaxin' at the US National Library of Medicine Medical Subject Headings (MeSH)
- "Relaxin". Human Protein Reference Database. Johns Hopkins University and the Institute of Bioinformatics. Retrieved 2009-05-20.
Lua error in Module:Authority_control at line 788: attempt to index field 'wikibase' (a nil value).
- Pages with script errors
- Pages with broken file links
- Genes on human chromosome 9
- Protein pages needing a picture
- Genes on human chromosome 19
- All articles with unsourced statements
- Articles with unsourced statements from August 2013
- Articles with invalid date parameter in template
- Peptide hormones
- Hormones of the ovary
- Hormones of the placenta
- Hormones of the pregnant female
- Human female endocrine system